24 HR mesalamine 375 MG Extended Release Oral Capsule
- RxCUI
- 825130
- RxNorm name
- 24 HR mesalamine 375 MG Extended Release Oral Capsule
- Display name
- 24 HR mesalamine 375 MG Extended Release Oral Capsule
- Full name
- 24 HR mesalamine 375 MG Extended Release Oral Capsule
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:05
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mesalamine | MESALAMINE | Golden State Medical Supply, Inc. | 4c4ffb68-3ca4-35cd-e063-6294a90ab929 | 2026-03-05 | Warnings, Adverse reactions | 825130 |
| MESALAMINE | MESALAMINE | Camber Pharmaceuticals, Inc. | ef471372-8d9f-4d95-9371-44522c69058f | 2025-12-10 | Warnings, Adverse reactions | 825130 |
| Mesalamine | MESALAMINE | Ingenus Pharmaceuticals, LLC | 58503afe-b8d4-4710-a194-e3acd64ecf1f | 2025-12-05 | Warnings, Adverse reactions | 825130 |
| Mesalamine | MESALAMINE | Upsher-Smith Laboratories, LLC | 1e6978d0-01db-477d-a90f-27561777480f | 2025-12-01 | Warnings, Adverse reactions | 825130 |
| Mesalamine | MESALAMINE | American Health Packaging | e638681d-8fca-4bf8-a1fb-8e52357a64da | 2025-05-21 | Warnings, Adverse reactions | 825130 |
| Mesalamine | MESALAMINE | AvPAK | f2657911-6f06-71fb-e053-2a95a90ae6f7 | 2025-01-09 | Warnings, Adverse reactions | 825130 |
| Mesalamine | MESALAMINE | Zydus Lifesciences Limited | 04073681-a834-4f45-91c5-224b608b30e6 | 2024-11-30 | 825130 | |
| Mesalamine | MESALAMINE | Ascend Laboratories, LLC | 43f69db3-81ac-4da4-a61f-fbba6299d9c2 | 2024-07-03 | Warnings, Adverse reactions | 825130 |
| Mesalamine | MESALAMINE | Aurobindo Pharma Limited | d6c0fc76-644e-4301-9672-f432061e3d37 | 2024-01-20 | Warnings, Adverse reactions | 825130 |
| APRISO | MESALAMINE | Salix Pharmaceuticals, Inc. | 7951139c-b271-45a4-b523-34b23800917b | 2024-01-09 | Warnings, Adverse reactions | 825130 |
| MESALAMINE | MESALAMINE | Alembic Pharmaceuticals Inc. | 87d3d62d-2dc3-4e6f-be33-cabbca12e8f7 | 2024-01-09 | Warnings, Adverse reactions | 825130 |
| mesalamine | MESALAMINE | Teva Pharmaceuticals USA, Inc. | 8d27a608-3ba1-4799-be38-c00fb08ce3ce | 2023-12-19 | Warnings, Adverse reactions | 825130 |
| Mesalamine | MESALAMINE | Mylan Pharmaceuticals Inc. | c8b93ea3-0367-4605-b87f-06c3812ff3b7 | 2023-11-30 | Warnings, Adverse reactions | 825130 |
| mesalamine | MESALAMINE | Oceanside Pharmaceuticals | cfe4800f-868f-46fd-8b9a-977a91ae5fbe | 2023-10-31 | Warnings, Adverse reactions | 825130 |
| Mesalamine | MESALAMINE | Zydus Pharmaceuticals USA Inc. | cd8493f7-91fd-4c2d-b3d7-c1301825586b | 2023-10-26 | Warnings, Adverse reactions | 825130 |
| MESALAMINE | MESALAMINE | Alembic Pharmaceuticals Limited | 4ef59b85-e5a5-479f-a1fe-e1cee4d87670 | 2022-11-07 | Warnings, Adverse reactions | 825130 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 7951139c-b271-45a4-b523-34b23800917b | mesalamine 0.375 GM 24HR Extended Release Oral Capsule | PSN | 34 | These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO ® (mesalamine) extended-release capsules Initial U.S. Approval: 1987 | 20240109 |
| 7951139c-b271-45a4-b523-34b23800917b | mesalazine 375 MG 24 HR Extended Release Oral Capsule | SY | 34 | These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO ® (mesalamine) extended-release capsules Initial U.S. Approval: 1987 | 20240109 |
| 7951139c-b271-45a4-b523-34b23800917b | mesalamine 375 MG 24 HR Extended Release Oral Capsule | SY | 34 | These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO ® (mesalamine) extended-release capsules Initial U.S. Approval: 1987 | 20240109 |
| 7951139c-b271-45a4-b523-34b23800917b | 24 HR mesalamine 375 MG Extended Release Oral Capsule | SCD | 34 | These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO ® (mesalamine) extended-release capsules Initial U.S. Approval: 1987 | 20240109 |
| 43f69db3-81ac-4da4-a61f-fbba6299d9c2 | mesalazine 375 MG 24 HR Extended Release Oral Capsule | SY | 14 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987 | 20240703 |
| 43f69db3-81ac-4da4-a61f-fbba6299d9c2 | 24 HR mesalamine 375 MG Extended Release Oral Capsule | SCD | 14 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987 | 20240703 |
| 43f69db3-81ac-4da4-a61f-fbba6299d9c2 | mesalamine 375 MG 24 HR Extended Release Oral Capsule | SY | 14 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987 | 20240703 |
| 43f69db3-81ac-4da4-a61f-fbba6299d9c2 | mesalamine 0.375 GM 24HR Extended Release Oral Capsule | PSN | 14 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987 | 20240703 |
| cfe4800f-868f-46fd-8b9a-977a91ae5fbe | mesalazine 375 MG 24 HR Extended Release Oral Capsule | SY | 9 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987 | 20231031 |
| cfe4800f-868f-46fd-8b9a-977a91ae5fbe | 24 HR mesalamine 375 MG Extended Release Oral Capsule | SCD | 9 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987 | 20231031 |
| cfe4800f-868f-46fd-8b9a-977a91ae5fbe | mesalamine 375 MG 24 HR Extended Release Oral Capsule | SY | 9 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987 | 20231031 |
| cfe4800f-868f-46fd-8b9a-977a91ae5fbe | mesalamine 0.375 GM 24HR Extended Release Oral Capsule | PSN | 9 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987 | 20231031 |
| 8d27a608-3ba1-4799-be38-c00fb08ce3ce | mesalamine 375 MG 24 HR Extended Release Oral Capsule | SY | 8 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987 | 20231219 |
| 8d27a608-3ba1-4799-be38-c00fb08ce3ce | mesalazine 375 MG 24 HR Extended Release Oral Capsule | SY | 8 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987 | 20231219 |
| 8d27a608-3ba1-4799-be38-c00fb08ce3ce | mesalamine 0.375 GM 24HR Extended Release Oral Capsule | PSN | 8 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987 | 20231219 |
| 8d27a608-3ba1-4799-be38-c00fb08ce3ce | 24 HR mesalamine 375 MG Extended Release Oral Capsule | SCD | 8 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987 | 20231219 |
| 87d3d62d-2dc3-4e6f-be33-cabbca12e8f7 | mesalamine 0.375 GM 24HR Extended Release Oral Capsule | PSN | 7 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20240109 |
| 87d3d62d-2dc3-4e6f-be33-cabbca12e8f7 | 24 HR mesalamine 375 MG Extended Release Oral Capsule | SCD | 7 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20240109 |
| 87d3d62d-2dc3-4e6f-be33-cabbca12e8f7 | mesalazine 375 MG 24 HR Extended Release Oral Capsule | SY | 7 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20240109 |
| 87d3d62d-2dc3-4e6f-be33-cabbca12e8f7 | mesalamine 375 MG 24 HR Extended Release Oral Capsule | SY | 7 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20240109 |
| d6c0fc76-644e-4301-9672-f432061e3d37 | mesalamine 0.375 GM 24HR Extended Release Oral Capsule | PSN | 5 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20240120 |
| d6c0fc76-644e-4301-9672-f432061e3d37 | mesalamine 375 MG 24 HR Extended Release Oral Capsule | SY | 5 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20240120 |
| d6c0fc76-644e-4301-9672-f432061e3d37 | mesalazine 375 MG 24 HR Extended Release Oral Capsule | SY | 5 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20240120 |
| d6c0fc76-644e-4301-9672-f432061e3d37 | 24 HR mesalamine 375 MG Extended Release Oral Capsule | SCD | 5 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20240120 |
| c8b93ea3-0367-4605-b87f-06c3812ff3b7 | 24 HR mesalamine 375 MG Extended Release Oral Capsule | SCD | 5 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES . MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20231130 |
| c8b93ea3-0367-4605-b87f-06c3812ff3b7 | mesalazine 375 MG 24 HR Extended Release Oral Capsule | SY | 5 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES . MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20231130 |
| c8b93ea3-0367-4605-b87f-06c3812ff3b7 | mesalamine 0.375 GM 24HR Extended Release Oral Capsule | PSN | 5 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES . MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20231130 |
| c8b93ea3-0367-4605-b87f-06c3812ff3b7 | mesalamine 375 MG 24 HR Extended Release Oral Capsule | SY | 5 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES . MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20231130 |
| 1e6978d0-01db-477d-a90f-27561777480f | mesalazine 375 MG 24 HR Extended Release Oral Capsule | SY | 4 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20251201 |
| 1e6978d0-01db-477d-a90f-27561777480f | mesalamine 0.375 GM 24HR Extended Release Oral Capsule | PSN | 4 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20251201 |
| 1e6978d0-01db-477d-a90f-27561777480f | 24 HR mesalamine 375 MG Extended Release Oral Capsule | SCD | 4 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20251201 |
| 1e6978d0-01db-477d-a90f-27561777480f | mesalamine 375 MG 24 HR Extended Release Oral Capsule | SY | 4 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20251201 |
| e638681d-8fca-4bf8-a1fb-8e52357a64da | mesalazine 375 MG 24 HR Extended Release Oral Capsule | SY | 4 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987 | 20250521 |
| e638681d-8fca-4bf8-a1fb-8e52357a64da | 24 HR mesalamine 375 MG Extended Release Oral Capsule | SCD | 4 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987 | 20250521 |
| e638681d-8fca-4bf8-a1fb-8e52357a64da | mesalamine 375 MG 24 HR Extended Release Oral Capsule | SY | 4 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987 | 20250521 |
| e638681d-8fca-4bf8-a1fb-8e52357a64da | mesalamine 0.375 GM 24HR Extended Release Oral Capsule | PSN | 4 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules Initial U.S. Approval: 1987 | 20250521 |
| cd8493f7-91fd-4c2d-b3d7-c1301825586b | mesalamine 0.375 GM 24HR Extended Release Oral Capsule | PSN | 4 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20231026 |
| cd8493f7-91fd-4c2d-b3d7-c1301825586b | 24 HR mesalamine 375 MG Extended Release Oral Capsule | SCD | 4 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20231026 |
| cd8493f7-91fd-4c2d-b3d7-c1301825586b | mesalamine 375 MG 24 HR Extended Release Oral Capsule | SY | 4 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20231026 |
| cd8493f7-91fd-4c2d-b3d7-c1301825586b | mesalazine 375 MG 24 HR Extended Release Oral Capsule | SY | 4 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20231026 |
| 04073681-a834-4f45-91c5-224b608b30e6 | mesalazine 375 MG 24 HR Extended Release Oral Capsule | SY | 3 | MESALAMINE Extended-Release Capsules | 20241130 |
| 04073681-a834-4f45-91c5-224b608b30e6 | 24 HR mesalamine 375 MG Extended Release Oral Capsule | SCD | 3 | MESALAMINE Extended-Release Capsules | 20241130 |
| 04073681-a834-4f45-91c5-224b608b30e6 | mesalamine 375 MG 24 HR Extended Release Oral Capsule | SY | 3 | MESALAMINE Extended-Release Capsules | 20241130 |
| 04073681-a834-4f45-91c5-224b608b30e6 | mesalamine 0.375 GM 24HR Extended Release Oral Capsule | PSN | 3 | MESALAMINE Extended-Release Capsules | 20241130 |
| ef471372-8d9f-4d95-9371-44522c69058f | mesalazine 375 MG 24 HR Extended Release Oral Capsule | SY | 2 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20251210 |
| ef471372-8d9f-4d95-9371-44522c69058f | mesalamine 0.375 GM 24HR Extended Release Oral Capsule | PSN | 2 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20251210 |
| ef471372-8d9f-4d95-9371-44522c69058f | mesalamine 375 MG 24 HR Extended Release Oral Capsule | SY | 2 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20251210 |
| ef471372-8d9f-4d95-9371-44522c69058f | 24 HR mesalamine 375 MG Extended Release Oral Capsule | SCD | 2 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20251210 |
| 58503afe-b8d4-4710-a194-e3acd64ecf1f | mesalazine 375 MG 24 HR Extended Release Oral Capsule | SY | 2 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES s afely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES . MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20251205 |
| 58503afe-b8d4-4710-a194-e3acd64ecf1f | mesalamine 0.375 GM 24HR Extended Release Oral Capsule | PSN | 2 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES s afely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES . MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20251205 |
| 58503afe-b8d4-4710-a194-e3acd64ecf1f | mesalamine 375 MG 24 HR Extended Release Oral Capsule | SY | 2 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES s afely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES . MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20251205 |
| 58503afe-b8d4-4710-a194-e3acd64ecf1f | 24 HR mesalamine 375 MG Extended Release Oral Capsule | SCD | 2 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES s afely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES . MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20251205 |
| f2657911-6f06-71fb-e053-2a95a90ae6f7 | mesalamine 375 MG 24 HR Extended Release Oral Capsule | SY | 2 | Mesalamine Extended Release Rx Only These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. Initial U.S. Approval: 1987 | 20250109 |
| f2657911-6f06-71fb-e053-2a95a90ae6f7 | mesalamine 0.375 GM 24HR Extended Release Oral Capsule | PSN | 2 | Mesalamine Extended Release Rx Only These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. Initial U.S. Approval: 1987 | 20250109 |
| f2657911-6f06-71fb-e053-2a95a90ae6f7 | mesalazine 375 MG 24 HR Extended Release Oral Capsule | SY | 2 | Mesalamine Extended Release Rx Only These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. Initial U.S. Approval: 1987 | 20250109 |
| f2657911-6f06-71fb-e053-2a95a90ae6f7 | 24 HR mesalamine 375 MG Extended Release Oral Capsule | SCD | 2 | Mesalamine Extended Release Rx Only These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. Initial U.S. Approval: 1987 | 20250109 |
| d5d05b1f-9f45-4f66-9f75-3c67934105de | mesalazine 375 MG 24 HR Extended Release Oral Capsule | SY | 2 | These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO™ (mesalamine) extended-release capsules Initial U.S. Approval: 1987 | 20120215 |
| d5d05b1f-9f45-4f66-9f75-3c67934105de | mesalamine 375 MG 24 HR Extended Release Oral Capsule | SY | 2 | These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO™ (mesalamine) extended-release capsules Initial U.S. Approval: 1987 | 20120215 |
| d5d05b1f-9f45-4f66-9f75-3c67934105de | 24 HR mesalamine 375 MG Extended Release Oral Capsule | SCD | 2 | These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO™ (mesalamine) extended-release capsules Initial U.S. Approval: 1987 | 20120215 |
| d5d05b1f-9f45-4f66-9f75-3c67934105de | mesalamine 0.375 GM 24HR Extended Release Oral Capsule | PSN | 2 | These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO™ (mesalamine) extended-release capsules Initial U.S. Approval: 1987 | 20120215 |
| 4c4ffb68-3ca4-35cd-e063-6294a90ab929 | 24 HR mesalamine 375 MG Extended Release Oral Capsule | SCD | 1 | MESALAMINE EXTENDED-RELEASE CAPSULES. These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20260305 |
| 4c4ffb68-3ca4-35cd-e063-6294a90ab929 | mesalazine 375 MG 24 HR Extended Release Oral Capsule | SY | 1 | MESALAMINE EXTENDED-RELEASE CAPSULES. These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20260305 |
| 4c4ffb68-3ca4-35cd-e063-6294a90ab929 | mesalamine 375 MG 24 HR Extended Release Oral Capsule | SY | 1 | MESALAMINE EXTENDED-RELEASE CAPSULES. These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20260305 |
| 4c4ffb68-3ca4-35cd-e063-6294a90ab929 | mesalamine 0.375 GM 24HR Extended Release Oral Capsule | PSN | 1 | MESALAMINE EXTENDED-RELEASE CAPSULES. These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20260305 |
| 4ef59b85-e5a5-479f-a1fe-e1cee4d87670 | mesalamine 0.375 GM 24HR Extended Release Oral Capsule | PSN | 1 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20221107 |
| 4ef59b85-e5a5-479f-a1fe-e1cee4d87670 | 24 HR mesalamine 375 MG Extended Release Oral Capsule | SCD | 1 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20221107 |
| 4ef59b85-e5a5-479f-a1fe-e1cee4d87670 | mesalamine 375 MG 24 HR Extended Release Oral Capsule | SY | 1 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20221107 |
| 4ef59b85-e5a5-479f-a1fe-e1cee4d87670 | mesalazine 375 MG 24 HR Extended Release Oral Capsule | SY | 1 | These highlights do not include all the information needed to use MESALAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for MESALAMINE EXTENDED-RELEASE CAPSULES. MESALAMINE extended-release capsules, for oral use Initial U.S. Approval: 1987 | 20221107 |